Back to results
US 2021/0268041 A1Published application
Non-viable bifidobacterium bifidum bacteria and uses thereof
AssigneeSynformulas GmbH
InventorClemens FISCHER
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeSynformulas GmbH
InventorClemens FISCHER
Estimating the term…
The present invention relates to non-viable bacteria of the Bifidobacterium bifidum strain SYN-HI-001 deposited under deposit No. DSM 24514, or one or more fragments thereof, for use in therapy, particularly for use in treating a gastrointestinal disorder, such as irritable bowel syndrome. Furthermore, the present invention relates to a composition comprising, as an active ingredient, said non-viable bacteria for use in therapy, particularly for use in treating a gastrointestinal disorder. Also, the present invention relates to a method of preparing non-viable bacteria of the Bifidobacterium bifidum strain SYN-HI-001 deposited under deposit No. DSM 24514, or one or more fragments thereof, and to bacteria obtained by the inventive method for use in therapy, particularly for use in treating a gastrointestinal disorder.
1-3. (canceled)
A composition comprising, as an active ingredient, non-viable bacteria of the Bifidobacterium bifidum strain SYN-HI-001 deposited under deposit No. DSM 24514, or one or more fragments thereof.
(canceled)
A method of preparing non-viable bacteria of the Bifidobacterium bifidum strain SYN-HI-001 deposited under deposit No. DSM 24514, or one or more fragments thereof, the method comprising:
-11. (canceled)
(canceled)
A method of treating a gastrointestinal disorder, the method comprising administering non-viable bacteria of the Bifidobacterium bifidum strain SYN-HI-001 deposited under deposit No. DSM 24514, or one or more fragments thereof, to a subject in need thereof.
(canceled)
Dependencies are inferred from the claim text.